Your browser doesn't support javascript.
loading
Validity of a novel computerized cognitive battery for mild cognitive impairment.
Dwolatzky, Tzvi; Whitehead, Victor; Doniger, Glen M; Simon, Ely S; Schweiger, Avraham; Jaffe, Dena; Chertkow, Howard.
Afiliação
  • Dwolatzky T; Memory Disorders Clinic and Dept. of Geriatrics, Shaare Zedek Medical Center, Jerusalem, Israel. tzvidov@bgumail.bgu.ac.il
BMC Geriatr ; 3: 4, 2003 Nov 02.
Article em En | MEDLINE | ID: mdl-14594456
ABSTRACT

BACKGROUND:

The NeuroTrax Mindstreams computerized cognitive assessment system was designed for widespread clinical and research use in detecting mild cognitive impairment (MCI). However, the capability of Mindstreams tests to discriminate elderly with MCI from those who are cognitively healthy has yet to be evaluated. Moreover, the comparability between these tests and traditional neuropsychological tests in detecting MCI has not been examined.

METHODS:

A 2-center study was designed to assess discriminant validity of tests in the Mindstreams Mild Impairment Battery. Participants were 30 individuals diagnosed with MCI, 29 with mild Alzheimer's disease (AD), and 39 healthy elderly. Testing was with the Mindstreams battery and traditional neuropsychological tests. Receiver operating characteristic (ROC) analysis was used to examine the ability of Mindstreams and traditional measures to discriminate those with MCI from cognitively healthy elderly. Between-group comparisons were made (Mann-Whitney U test) between MCI and healthy elderly and between MCI and mild AD groups.

RESULTS:

Mindstreams outcome parameters across multiple cognitive domains significantly discriminated among MCI and healthy elderly with considerable effect sizes (p < 0.05). Measures of memory, executive function, visual spatial skills, and verbal fluency discriminated best, and discriminability was at least comparable to that of traditional neuropsychological tests in these domains.

CONCLUSIONS:

Mindstreams tests are effective in detecting MCI, providing a comprehensive profile of cognitive function. Further, the enhanced precision and ease of use of these computerized tests make the NeuroTrax system a valuable clinical tool in the identification of elderly at high risk for dementia.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2003 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2003 Tipo de documento: Article